Shanghai Medical University Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2005
NCT00133627
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Hospital of Shanghai Medical University | Shanghai Nanhui Nanhua Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Conjunctivitis (Phase 4)

Conjunctivitis, Allergic (Phase 4)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 4